Satoru Kakizaki

Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study

Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka et al. · Hepatology International · 2022 · 80 citations

Medicine, Oncology, Pharmacotherapy +17

Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice

Takaaki Tanaka, Atsushi Hiraoka, Toshifumi Tada et al. · Hepatology Research · 2022 · 78 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study

Eunice Tan, Jonathan Lee, Nur Halisah Binte Jumat et al. · Metabolism · 2021 · 61 citations · Full text

Medicine, Internal Medicine, Pathology +17

Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter

Junko Sugatani, Kousuke Mizushima, Makoto Osabe et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2008 · 57 citations

Life Sciences, Genetics, Molecular Biology +17

Hepatocellular carcinoma in extremely elderly patients: An analysis of clinical characteristics, prognosis and patient survival

Gengo Tsukioka, Satoru Kakizaki, Naondo Sohara et al. · World Journal of Gastroenterology · 2006 · 55 citations · Full text

Medicine, Geriatric Medicine, Oncology +16